After years of raising co-payments and deductibles for prescription drugs, some employers are taking an unorthodox approach to lowering health-care costs. Now get this, they are paying for drugs and consultations that go along with them. Larry Boress, president of the Midwest Business Group on Health, tells the Chicago Tribune's Bruce Japsen about this unique approach to controlling prescription spending.
ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Employers' New Drug Cost Control: Pay for Them!
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
After years of raising co-payments and deductibles for prescription drugs, some employers are taking an unorthodox approach to lowering health-care costs. Now get this, they are paying for drugs and consultations that go along with them. Larry Boress, president of the Midwest Business Group on Health, tells the Chicago Tribune's Bruce Japsen about this unique approach to controlling prescription spending.
Presenters
Facebook Comments